1826 - 1850 of 7939 Results
Title
Year
-
OPENTitle: Patterns of Beginning of Dose Motor Deterioration: A New Look at an Old PhenomenonJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 5Start Page: 712End Page: 716Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13470Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13470Citation Count: 1
-
RESTRICTEDTitle: The chaperone Clusterin in neurodegeneration−friend or foe?Journal Name: BioEssaysPublisher: WileyVol: 44Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/bies.202100287Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bies.202100287Citation Count: 20
- A Markov random field model-based approach for differentially expressed gene detection from single-cell RNA-seq data2022OPENTitle: A Markov random field model-based approach for differentially expressed gene detection from single-cell RNA-seq dataJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/bib/bbac166Best OA location URL: https://academic.oup.com/bib/article-pdf/23/5/bbac166/45937268/bbac166.pdfCitation Count: 5
-
OPENTitle: ATXN2 intermediate expansions in amyotrophic lateral sclerosisJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 8Start Page: 2671End Page: 2676Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac167Best OA location URL: https://academic.oup.com/brain/article-pdf/145/8/2671/49017873/awac167.pdfCitation Count: 23
- Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiative2022OPENTitle: Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 37Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/gps.5727Best OA location URL: https://psyarxiv.com/rxqev/downloadCitation Count: 3
- Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord2022OPENTitle: Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cordJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 9Start Page: 3108End Page: 3130Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac165Best OA location URL: https://academic.oup.com/brain/article-pdf/145/9/3108/45824171/awac165.pdfCitation Count: 41
- Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes2022OPENTitle: Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetesJournal Name: Pharmacoepidemiology and Drug SafetyPublisher: WileyVol: 31Issue #: 8Start Page: 875End Page: 882Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pds.5448Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542001Citation Count: 12
- Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing2022OPENTitle: Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editingJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 62Issue #:Start Page: 102806End Page: 102806Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2022.102806Best OA location URL: https://doi.org/10.1016/j.scr.2022.102806Citation Count: 11
- Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s disease2022RESTRICTEDTitle: Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4745End Page: 4752Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-06110-yCitation Count: 6
- Vocal changes in a zebra finch model of Parkinson’s disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathway2022OPENTitle: Vocal changes in a zebra finch model of Parkinson’s disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathwayJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 5Start Page: e0265604End Page: e0265604Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0265604Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0265604&type=printableCitation Count: 8
- Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes2022OPENTitle: Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromesJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-00983-zBest OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-022-00983-zCitation Count: 13
- Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms2022OPENTitle: Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN ProteoformsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 5Start Page: 1449End Page: 1462Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223285Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223285?id=journal-of-parkinsons-disease%2Fjpd223285Citation Count: 9
- Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directions2022RESTRICTEDTitle: Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directionsJournal Name: Expert Opinion on Drug SafetyPublisher: Informa UK LimitedVol: 21Issue #: 7Start Page: 873End Page: 879Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14740338.2022.2069240Best OA location URL: https://doi.org/10.1080/14740338.2022.2069240Citation Count: 8
-
RESTRICTEDTitle: Incidence of Parkinson Disease in North America (P1-1.Virtual)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.2665Citation Count: 1
- Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)2022RESTRICTEDTitle: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 18_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529Citation Count: 2
- The Huntington’s Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure2022RESTRICTEDTitle: The Huntington’s Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome MeasureJournal Name: Journal of Huntington's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 2Start Page: 217End Page: 226Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jhd-210506Citation Count: 7
- SHIP164 is a chorein motif lipid transfer protein that controls endosome–Golgi membrane traffic2022OPENTitle: SHIP164 is a chorein motif lipid transfer protein that controls endosome–Golgi membrane trafficJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202111018Best OA location URL: https://rupress.org/jcb/article-pdf/221/6/e202111018/1432735/jcb_202111018.pdfCitation Count: 17
-
OPENTitle: Sleep, Pain, and Neurodegeneration: A Mendelian Randomization StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.765321Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.765321/pdfCitation Count: 11
-
OPENTitle: Structural basis for feedforward control in the PINK1/Parkin pathwayJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2021109460Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2021109460Citation Count: 20
-
OPENTitle: AbstractsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13411Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13411Citation Count: 5
-
RESTRICTEDTitle: Alternative protective group strategy for the radiosynthesis of Flortaucipir 18FJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 108-109Issue #:Start Page: S88End Page: S88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00208-6Citation Count: 0
-
OPENTitle: Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivoJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 3Issue #: 5Start Page: 100630End Page: 100630Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100630Best OA location URL: http://www.cell.com/article/S2666379122001550/pdfCitation Count: 16
-
RESTRICTEDTitle: Die Folgen der Schulgeldfreiheit – Wissenschaft nachgefragtJournal Name: physiopraxisPublisher: Georg Thieme Verlag KGVol: 20Issue #: 05Start Page: 12End Page: 13Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/a-1815-6034Citation Count: 1
- Exposure to Pesticides Predicts Prodromal Feature of Parkinson's Disease: Public Health Implications2022OPENTitle: Exposure to Pesticides Predicts Prodromal Feature of Parkinson's Disease: Public Health ImplicationsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 883End Page: 885Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29012Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/252078/252078.pdfCitation Count: 3
- Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trial2022OPENTitle: Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trialJournal Name: Brain StimulationPublisher: Elsevier BVVol: 15Issue #: 3Start Page: 857End Page: 860Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brs.2022.05.012Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X22000912/pdfCitation Count: 10